Flu Vaccination: Education is Imperative

Due to pervasive myths and other hurdles, many Americans do not realize the seriousness of the flu and the ways it can disrupt lives – even for healthy people. While the flu, or influenza, is often mistaken for the common cold, the flu is far worse and can lead to severe and even fatal complications, particularly in children. Last year, 167 children died due to the flu. That is the highest recorded number in a non-pandemic season. Flu vaccination is the single best preventative measure we have to protect against this highly-contagious disease and this important fact underscores the need for ongoing educational efforts to address this...

Creating a New Class of Vaccines

Vaccines are among the most cost-effective and successful health interventions ever developed, saving millions of lives each year. However, traditional vaccines are designed to target pathogens that live in the bloodstream. Many infectious diseases, such as herpes, chlamydia and malaria, live inside the body’s cells, leaving these serious illnesses literally beyond the reach of available technology—until now. Genocea Biosciences, an FKH client,  is working to develop the first vaccine that will trigger the body to destroy its own infected cells –something that has never before been possible, due to the volume of potential pathogen T...

Using new technologies to debunk HIV myths and enc...

Of the nearly 1.2 million people living with HIV in the U.S., almost one in five are unaware of their HIV positive status. Additionally, half of new infections are transmitted by people who don’t know they have the virus. At a time when unmet need is high, and more has to be accomplished with fewer resources, HIV advocates are finding innovative ways to raise awareness, mobilize communities and encourage HIV testing. For instance, HIV/AIDS service organizations are harnessing the power of new media to reduce fear and clear up misperceptions that can be roadblocks to testing, including: Testing is not needed because I’m not at risk....

Here’s to the Next 25

Feinstein Kean Healthcare has spent the past 25 years laboring productively in the vineyards of disruptive innovation. The firm was born in the cradle of biotech and worked with many of the industry’s pioneers. We were there in the early days of stem cell research, oncogenes and immunotherapies, nanotech, many of the “omics” and, more recently, big data, cognitive gaming and the digitization of medicine. We’ve helped to open up entirely new categories of treatment in many disease areas, and changed the mindset in others. We were the first in the communications industry to anticipate the impact of personalized medicine—and (thanks...